Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Ray Dingledine"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Generalized status epilepticus (SE) triggers a robust neuroinflammatory response involving reactive astrocytosis, activation of brain-resident microglia, and brain infiltration of CCR2+ monocytes. Multiple lines of evidence indicate that que
Externí odkaz:
https://doaj.org/article/d759dc1317e74a1d8ee0477da93dd162
Publikováno v:
Brain, Behavior, & Immunity - Health, Vol 8, Iss , Pp 100132- (2020)
Long-term cognitive and affective impairments are common problems in the survivors of sepsis, which weakens their vocational and daily life ability. Neuroinflammation has been reported to exert a key role in the development of cognitive deficit in di
Externí odkaz:
https://doaj.org/article/3ecfb40306af4b95b93ee7748eff3cc5
Autor:
Lynnea D. Harris, Michael C. Regan, Scott J. Myers, Kelsey A. Nocilla, Nicholas S. Akins, Yesim A. Tahirovic, Lawrence J. Wilson, Ray Dingledine, Hiro Furukawa, Stephen F. Traynelis, Dennis C. Liotta
Publikováno v:
ACS Chemical Neuroscience. 14:917-935
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12f338a85c3f3e0624b576a9e746af74
https://doi.org/10.1021/acschemneuro.2c00779
https://doi.org/10.1021/acschemneuro.2c00779
Autor:
Jeffrey C. Watkins, Michael Spedding, Peter Seeburg, John A. Peters, Stephane Peineau, Richard Olsen, Shigetada Nakanishi, Christophe Mulle, Masayoshi Mishina, Mark Mayer, David Lodge, Juan Lerma, Michael Hollmann, Stephen F. Heinemann, Ray Dingledine, Graham L. Collingridge, Bernhard Bettler
Publikováno v:
IUPHAR/BPS Guide to Pharmacology CITE. 2023
The ionotropic glutamate receptors comprise members of the NMDA (N-methyl-D-aspartate), AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid) and kainate receptor classes, named originally according to their preferred, synthetic, agonist [36,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9e976b02eab2c72a47db4f648b049cc
https://doi.org/10.2218/gtopdb/f75/2023.1
https://doi.org/10.2218/gtopdb/f75/2023.1
Publikováno v:
Clinical Pharmacology in Drug Development.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::777b95f5f367c0f5dc7dce4b9bca743c
https://doi.org/10.1002/cpdd.1217
https://doi.org/10.1002/cpdd.1217
Autor:
Ray Dingledine
Publikováno v:
Epilepsy Currents. :153575972311723
[Box: see text]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f0b69adebf0ab99aadb4f2a077772c6
https://doi.org/10.1177/15357597231172324
https://doi.org/10.1177/15357597231172324
Autor:
Jeffrey C. Watkins, Michael Spedding, Peter Seeburg, John A. Peters, Stephane Peineau, Richard Olsen, Shigetada Nakanishi, Christophe Mulle, Masayoshi Mishina, Mark Mayer, David Lodge, Juan Lerma, Michael Hollmann, Stephen F. Heinemann, Ray Dingledine, Graham L. Collingridge, Bernhard Bettler
Publikováno v:
IUPHAR/BPS Guide to Pharmacology CITE. 2021
The ionotropic glutamate receptors comprise members of the NMDA (N-methyl-D-aspartate), AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid) and kainate receptor classes, named originally according to their preferred, synthetic, agonist [35,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c26539c488a4492e77c060d98ab00ccb
https://doi.org/10.2218/gtopdb/f75/2021.3
https://doi.org/10.2218/gtopdb/f75/2021.3
Autor:
Jeffrey C. Watkins, Michael Spedding, Peter Seeburg, John A. Peters, Stephane Peineau, Richard Olsen, Shigetada Nakanishi, Christophe Mulle, Masayoshi Mishina, Mark Mayer, David Lodge, Juan Lerma, Michael Hollmann, Stephen F. Heinemann, Ray Dingledine, Graham L. Collingridge, Bernhard Bettler
Publikováno v:
IUPHAR/BPS Guide to Pharmacology CITE. 2019
The ionotropic glutamate receptors comprise members of the NMDA (N-methyl-D-aspartate), AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid) and kainate receptor classes, named originally according to their preferred, synthetic, agonist [34,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c6a427f5b55b74d0c962665463c6745
https://doi.org/10.2218/gtopdb/f75/2019.4
https://doi.org/10.2218/gtopdb/f75/2019.4
Autor:
Ray, Dingledine, Bjørnar, Hassel
Publikováno v:
Cerebrum: the Dana Forum on Brain Science
Editor’s Note: About one-third of the 65 million people worldwide affected by epilepsy are treatment-resistant, and the degree to which they suffer from seizures and convulsions can vary widely. Problems occur when nerve cells in the brain fail to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3aa5001fdcb973759eec83c07e6a5561
https://pubmed.ncbi.nlm.nih.gov/27408679
https://pubmed.ncbi.nlm.nih.gov/27408679
Autor:
Dennis, Dlugos, Greg, Worrell, Kathryn, Davis, William, Stacey, Jerzy, Szaflarski, Andres, Kanner, Sridhar, Sunderam, Mike, Rogawski, Patrice, Jackson-Ayotunde, Tobias, Loddenkemper, Beate, Diehl, Brandy, Fureman, Ray, Dingledine
Publikováno v:
Epilepsy currents. 16(3)
The goals of Epilepsy Benchmark Area III involve identifying areas that are ripe for progress in terms of controlling seizures and patient symptoms in light of the most recent advances in both basic and clinical research. These goals were developed w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90767b7751aa063939802938b4eaacc1
https://pubmed.ncbi.nlm.nih.gov/27330452
https://pubmed.ncbi.nlm.nih.gov/27330452